Premium
The prevention and treatment of postpartum haemorrhage: what do we know, and where do we go to next?
Author(s) -
Weeks A
Publication year - 2015
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/1471-0528.13098
Subject(s) - postpartum haemorrhage , medicine , misoprostol , placental abruption , uterotonic , obstetrics , blood loss , intensive care medicine , pregnancy , surgery , oxytocin , abortion , fetus , genetics , biology
Postpartum haemorrhage ( PPH ) remains a major cause of maternal deaths worldwide, and is estimated to cause the death of a woman every 10 minutes. This review presents the latest clinical advice, including new evidence on controlled cord traction, misoprostol, and oxytocin. The controversy around the diagnosis of PPH , the limitations of universal prophylaxis, and novel ways to provide obstetric first aid are also presented. It ends with a call to develop high‐quality front‐line obstetric services that can deal rapidly with unexpected haemorrhages as well as minimising blood loss at critical times: major abruption, placenta praevia, and caesarean for prolonged labour.